Alpha Tau Medical Ltd.

DRTS

$883M

Small Cap

NASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaJERUSALEM125 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 10, 2026

Market Overview

Stock performance and key metrics

DRTS News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

Drug Pipeline

AZD3759

Phase 3

Non-small Cell Lung Cancer

MTL-CEBPA

Phase 2

Hepatocellular Carcinoma

ZN-c5

Phase 2

Breast Cancer

Drug Name	Phase	Indication	Designations	Patent
AZD3759	Phase 3	Non-small Cell Lung Cancer	-	-
MTL-CEBPA	Phase 2	Hepatocellular Carcinoma	-	-
ZN-c5	Phase 2	Breast Cancer	-	-

Catalyst Verdict

Market-Implied Move

Regulatory Approvals

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Alpha Tau Medical Ltd.

Market Overview

DRTS News

Catalyst Timeline

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals